Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 20:16:21 +0200Thu, 15 Feb 2024 17:31:00 +0100Human medicines European public assessment report (EPAR): Hemgenix, etranacogene dezaparvovec, Date of authorisation: 20/02/2023, Revision: 3, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/hemgenixHuman medicines European public assessment report (EPAR): Hemgenix, etranacogene dezaparvovec, Date of authorisation: 20/02/2023, Revision: 3, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/hemgenixThu, 15 Feb 2024 17:31:00 +0100Human medicineHemgenix : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4827_en_1.pdfHemgenix : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4827_en_1.pdfThu, 15 Feb 2024 17:00:00 +0100Human medicine